LabCorp ramps up its COVID-19 molecular testing capacity to 200,000 tests per day

As part of its ongoing commitment to help meet testing needs, LabCorp (NC, USA) has announced that its COVID-19 molecular testing capacity has been increased to 200,000 tests per day. LabCorp’s first molecular test for COVID-19 was made available in March 2020 and, to date, the company has performed more than 12 million COVID-19 molecular tests. The scaling up of LabCorp’s capacity for daily COVID-19 molecular tests is a result of its ongoing commitment to help meet demands for testing, however, the volume of tests currently received by the organization on a daily basis falls below the newly expanded 200,000...